Tue, Jul 29, 2014, 4:42 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Boston Scientific Corporation Message Board

  • Proff1960 Proff1960 Jan 24, 1999 6:52 PM Flag

    BSX outlook

    I hate to be negative, but senior management has
    shown very little ability to execute their plans. Larry
    Best fights with the FDA and other senior managers
    report false sales in Japan. Shareholders are in line to
    sue the company and the latest stent (NIR) is loosing
    it's edge over competitors products. I have heard of
    no new products in the pipeline. VP of research is
    retiring. A conference call indicating that these problems
    will be solved does little to gain my confidence at
    this point. Long term (3+ years) this stock may be
    attractive if management can turn things around, but who has
    three years to wait? How long has it been since BSX
    beat even lowered earnings estimates? On the plus
    side, I have heard that November was not a bad month.
    We shall see next week. Delayed earnings will be a
    very bad sign.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 10:50AM EST BSX Heavy volume over 4 Million traded. High 43 1/4.

    • SVC - was supposed to be, sorry for the typo
      (Superior Vena Cava)Atrial Flair - this was an RA pacing
      catheter sold by MSC
      MSC - Mansfield Scientific Company
      (the interventional precusor to SciMed, when SciMed
      was making oxygenators, started by Peter and
      John)while SciMed was being re-tuned by John and Dale.

    • I talked with some people today who were with
      Biogen and Baxter (maybe Tobin likes to work with
      companies that start with the letter b) all of the
      commentary was positive. Tobin was certainly good for
      Biogen. Though he had problems with his previous bosses
      and left because of them. This situation may be
      something like the previous two.

      Tobin does seem to
      be very sharp. It will be interesting if your
      prediction of the CFO heave-ho comes true. BSC problems have
      come as the result of the functionaries that don't as
      you say and not lack of vision as the almost daily
      issuing of patents related to medical devices. I agree
      about the now former management.

      Scimed,
      before the merger, was being sued and losing lawsuits to
      a lot of co.s ; and they seem to be responsible for
      a good share of BSC's problems. And some of the old
      Scimed people were not very nice people; not the kind of
      people that you ususally meet in Minnesota. More
      streamlining ahead? Maybe the change to Tobin will be good for
      BSC. I am staying long for the near future.

    • Do you have the right info? SVG filter, atrial flair? never heard of these BSC products. Who are the MSC folks?

      little confused

    • On a day like this, when the knight in shining
      armour has finally shown up to deliver us from the other
      helmet headed cfo, we show our appreciation to the Beez,
      voice of reason in the benighted woods. Speaking of
      woods, where's woodfleet been lately?

    • Hey, Dip Sh.., two things. First of all, it's
      Brek! Secondly,
      I've never lived on a farm! Just to
      let you know, I rarely waste
      time on loser message
      boards like this one. Matter of fact, if
      someone
      hadn't pointed out that I was mentioned, I wouldn't
      be
      here now (and probably won't be here again!) Must be
      hard to get
      out and sell with one hand on the
      keyboard and the other wrapped
      around your johnson!

    • Hey, Dip Sh.., two things. First of all, it's
      Brek! Secondly,
      I've never lived on a farm! Just to
      let you know, I rarely waste
      time on loser message
      boards like this one. Matter of fact, if
      someone
      hadn't pointed out that I was mentioned, I wouldn't
      be
      here now (and probably won't be here again!) Must be
      hard to get
      out and sell with one hand on the
      keyboard and the other wrapped
      around your johnson!

    • Your right(route17cruzer) the accounting irregularities bother me also. Where there is smoke, there is fire, possibly were you don't expect it.

    • Greetings to all. I am new to this board and I am
      hoping to learn something about this stock of which I
      own a small amount. What happens in other companies
      when large accounting irregularities are uncovered?
      Can someone here come up with a good example where
      something like this happened? How was the problem handled?
      Isn't the CFO ultimately responsible for this? Did the
      CFO get 250,000 shares of stock recently? Of all the
      recent problems at BSX, the accounting irregularities
      concerns me the most. Recalls are unfortunate and some are
      certainly preventable, but they happen and you go on and
      try to do better the next time.

    • You're right, one doesn't want to admit there's a
      'knowledge gap' at the top. Employees want to think when the
      CFO gleefully states that 'The board of directors
      must think I'm doing a good job, they just granted me
      another 250,000 shares!' while cutting bonuses to the
      worker bees that there is a good business reason. One
      wants to think that when the CFO courts mistrust on the
      Street through his mis-handling of events during rough
      times that Pete is blind to his actions and has given
      his blessing, but you're right. The buck stops there.
      When the CFO is responsible for the audit department
      and overlooks massive accounting irregularities that
      lead to stock price decline, questionable hiring
      practices, and rampant over spending that this is part of
      the overall game plan for a strong company. Many lie
      to themselves to get through the day.

    • View More Messages
 
BSX
12.89-0.08(-0.62%)4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.